Comprehensive Notes on Virus Replication and Plant/Animal Viruses
Virus Fundamentals
Viruses are obligate, intracellular parasites: a virus must recognize and attach to a specific living cell, enter it, copy its genome and produce its proteins, then progeny virions must escape to infect other cells.
Host range and cell specificity are governed by:
Permissive host cells (those that support replication).
Viral receptors on the host cell surface that determine attachment specificity.
Differences in host metabolism and immune responses (via differential gene expression) that influence which cells a virus can replicate in.
Steps of virus infections can cause cytopathic effects (CPE): dramatic biochemical/structural changes in the host cell that can impair function or kill the cell.
Cytopathic outcomes vary by virus:
Some infected cells die by lysis or apoptosis, releasing progeny virions (e.g., rhinovirus common cold).
Others leave the host cell intact through budding, releasing virions individually (e.g., HIV); cells may remain alive longer but be functionally damaged.
Disease symptoms arise from both virus-induced cell damage and the host immune response aimed at controlling/eliminating the virus.
Productive infections typically follow these steps: attachment, penetration, uncoating, replication, assembly, and release.
The six canonical steps can be summarized as:
Entry can occur with or without the viral capsid; entry routes depend on genome type and whether the virus is naked or enveloped.
Bacteriophages (viruses that infect bacteria) inject naked genomes into the host, leaving the capsid outside.
Plant and animal viruses often enter via endocytosis; enveloped viruses may fuse their envelope with the host membrane to release the genome.
After entry, the viral capsid degrades and the viral nucleic acid is released for replication and transcription.
Transmission and disease features depend on virus type, host, and tissue tropism, as well as immune responses.
Entry, Replication, and Genome Multipliers
Entry methods vary by virus type:
Naked (non-enveloped) viruses can enter via receptor-mediated endocytosis or by receptor-induced changes in capsid proteins that form channels for injection of the genome.
Enveloped viruses can enter via receptor-mediated endocytosis or by membrane fusion (the latter only for enveloped viruses).
Once inside, replication strategies depend on the genome:
DNA viruses: typically use host-cell enzymes for DNA replication and transcription of viral mRNA, which then directs viral protein synthesis.
RNA viruses: generally use the RNA core as a template to synthesize genomic RNA and mRNA; viral mRNA then directs synthesis of viral enzymes and capsid proteins for assembly.
Exceptions exist; if the host lacks necessary enzymes, viral genes provide the missing proteins.
Retroviruses (e.g., HIV) have RNA genomes that must be reverse-transcribed into DNA and integrated into the host genome:
They carry the enzyme reverse transcriptase (RT) to convert RNA to DNA.
Reverse transcription occurs only because the viral genome encodes this enzyme; uninfected host cells do not perform this step.
The integrated provirus allows persistent infection and is a target for antiviral drugs that inhibit viral enzymes (e.g., RT inhibitors).
The existence of viral enzymes not found in the host has enabled the development of targeted antiviral therapies that reduce infectious virions in the bloodstream.
Egress (release) is the final stage:
Some viruses are released by cell lysis, killing the host cell.
Others exit by budding through the membrane, which may allow the host cell to survive temporarily while virions bud off.
Visual example (influenza cycle): enveloped influenza virions use surface glycoproteins to attach to epithelial cells, are endocytosed, and then assemble and release via budding, enabling cell survival during egress.
Influenza Life Cycle (Visual Context)
Glycoproteins on the viral envelope attach to host epithelial cells; endocytosis follows, RNA and proteins are synthesized and assembled into new virions.
The viral envelope fuses with the plasma membrane, allowing release of the genome and viral proteins without necessarily killing the host cell.
Question to consider: what advantage does keeping the host cell alive confer for the virus? (Prolonged replication potential, reduced immune detection, etc.)
How Virus Entry and Replication Relate to Hosts
Host specificity means most viruses infect only specific species and cell types within those species.
Prokaryotes host bacteriophages (dsDNA phages common); Archaea have their own viruses; bacteriophages provide model systems for lytic vs lysogenic cycles.
Bacteriophages: Lytic and Lysogenic Cycles
Bacteriophages often have dsDNA genomes and rely on host enzymes for DNA replication and transcription; they must bind to specific surface receptors and inject their genome.
Productive infection yields new virions; if released by lysis, the phage follows the lytic cycle (Figure 21.10).
Temperate phages can enter a lysogenic cycle, where phage DNA integrates into the host genome as a prophage, propagating with the host cell division.
Example: λ (lambda) phage infecting E. coli.
Prophage may be induced to enter the lytic cycle under environmental stress (starvation, toxins).
Plant and animal viruses sometimes display latency rather than immediate virion production; herpesviruses are classic examples of latency in nervous tissue.
Note: there are similarities between lysogeny (phages) and latency (animal viruses), but the term lysogenic cycle is typically used for bacteriophages.
Plant Viruses: Entry, Movement, Symptoms, and Transmission
Plant viruses often have (+) single-stranded RNA genomes (ssRNA(+)); they can lack active mechanisms to breach plant cell walls and entry commonly requires mechanical damage.
Plant viruses can move cell-to-cell through plasmodesmata (cytoplasmic channels between plant cells) with viral adaptations that modify these channels.
Entry into a new plant host is often via mechanical damage from weather, insects, animals, fire, or human activity (farming, landscaping).
Within a plant, viral movement to adjacent cells and tissues occurs through plasmodesmata, aided by viral proteins that modify these channels.
Symptoms and economic impact:
Plant viruses cause hyperplasia (galls), hypoplasia (decreased cell growth), necrosis, malformed growth, and various discolorations.
Symptoms vary by virus and host; common signs include hyperplasia, galls, necrosis, and mosaic patterns.
Plant viruses significantly affect crop yield and quality, leading to substantial economic losses globally; landscaping plants can also be affected.
Example plant viruses and hosts:
Tomato spotted wilt virus, bean common mosaic virus, cucumber mosaic virus (agricultural crops).
Ornamental plant viruses include peony ring spot and rose mosaic virus.
Horizontal transmission (between plants) and vertical transmission (from parent to offspring) are both possible routes for plant viruses through sap, vectors, pollen, etc.
Plant symptoms tabulated (conceptual): hyperplasia, hypoplasia, necrosis, malformed growth, and discoloration are key indicators across different plant-virus interactions.
Animal Viruses: Entry, Replication, and Disease Outcomes
Animal viruses bypass the plant cell wall and can induce host cell cooperation in infection.
Entry routes for animal viruses:
Naked (non-enveloped) viruses can enter via receptor-mediated endocytosis or by capsid proteins changing shape to create membrane channels that inject the genome.
Enveloped viruses can enter via receptor-mediated endocytosis or by fusion; fusion requires envelope proteins that fuse the viral envelope with the host plasma membrane.
After entry, host-cell machinery is used to translate viral proteins and copy viral genomes; new virions are assembled and released.
Egress for enveloped animal viruses often occurs by budding, which acquires a portion of the host cell membrane as the viral envelope. Non-enveloped viruses typically accumulate until lysis or apoptosis occurs for release.
Disease patterns in animal viruses:
Acute infections: symptoms intensify over a short period and are cleared by the immune system (e.g., common cold, influenza).
Chronic infections: persistent replication with ongoing immune response (e.g., hepatitis C).
Latent infections: virus remains dormant in host tissues and may reactivate under stress (e.g., herpes simplex virus). Latency is common in herpesviruses.
Asymptomatic infections: productive infections without noticeable symptoms (e.g., some human herpesviruses 6 and 7; roseola). Immunity may wane, allowing reactivation or persistence.
Hepatitis C virus: chronic infection in liver, low-level damage, often undetected without risk-factor screening; chronic infection increases risk of liver cancer over time.
Herpesviruses: latency in nervous tissue, periodically reactivating to cause lesions; cold sores and genital herpes can recur due to intermittent lytic cycles.
Varicella-zoster virus (VZV): causes chickenpox in childhood and can remain latent in ganglia; reactivation in adulthood causes shingles (herpes zoster).
Oncogenic (cancer-causing) viruses exist among both DNA and RNA viruses:
They can disrupt cell cycle regulation by introducing oncogenes or by inhibiting tumor-suppressor pathways.
Associated cancers include cervical cancer (HPV), liver cancer (hepatitis C), T-cell leukemia, and several lymphomas.
Human papillomavirus (HPV) is a well-known oncogenic virus with a naked icosahedral capsid and a dsDNA genome that integrates into the host genome and is sexually transmitted, contributing to cervical cancer risk.
Oncogenic Viruses and Cancer Connections
Oncogenic viruses exert cancer risk by:
Introducing viral genes that promote unregulated cell growth (oncogenes).
Interfering with host genes that normally inhibit cell division.
Cancer associations by virus type span multiple tissues and cancer forms, illustrating the diverse ways viruses can contribute to oncogenesis.
Key Takeaways: Viral Life Cycles, Host Range, and Disease Implications
Viral replication requires harnessing host-cell processes across all life cycle stages, with host range determined by receptor compatibility and intracellular milieu.
The six classic steps of viral replication are universally relevant: . These steps produce cytopathic effects that, together with host immune responses, shape disease outcomes.
DNA vs RNA genome strategies reflect different dependencies on host vs viral enzymes; retroviruses uniquely encode reverse transcriptase to convert RNA to DNA and integrate into the host genome.
Egress strategies (budding vs lysis) influence both virus propagation and host cell fate; enveloped viruses often exit by budding, potentially preserving the host cell longer, while non-enveloped viruses commonly cause lysis.
Virus-host specificity is evident across domains: bacteriophages infect bacteria, plant viruses require mechanical damage to breach cell walls and spread via plasmodesmata, and animal viruses use a variety of entry and replication strategies.
Plant viruses can cause substantial agricultural and economic impact due to yield loss, quality degradation, and ornamental plant damage; transmission can be horizontal (between plants) or vertical (from parent to offspring).
Animal viruses contribute to a broad spectrum of diseases from acute to chronic to latent; some viruses are asymptomatic yet persist, while others (e.g., HPV, hepatitis C) carry long-term cancer risks.
Understanding of viral entry, replication, and egress informs therapeutic strategies, including antiviral drugs targeting viral enzymes (e.g., reverse transcriptase) that exploit differences between viral and host metabolism.
Quick Reference: Notable Terms and Concepts
Permissive cell: a host cell that supports viral replication.
Viral receptor: host cell surface molecule required for viral attachment.
Cytopathic effect (CPE): virus-induced changes/damages in host cells.
Budding: virions exit by acquiring a portion of the host cell membrane; often preserves host cells.
Lysis: destruction of the host cell, releasing virions.
Latency: virus persists in host tissue with little or no viral protein production, potentially reactivating later.
Prophage: integrated viral genome within a bacterial host genome.
Provirus: viral genome integrated within a eukaryotic host genome (as in retroviruses).
Oncogenic virus: a virus capable of contributing to cancer development.
Plasmodesmata: cytoplasmic channels in plant cell walls that viruses can modify to move between cells.
Horizontal transmission: movement of a virus between individuals of the same generation.
Vertical transmission: transmission from parent to offspring.
dsDNA vs ssRNA(+)/RNA genomes: distinct genome types that drive different replication strategies.
Reverse transcriptase (RT): enzyme used by retroviruses to synthesize DNA from RNA.
Example pathogens mentioned: rhinovirus, influenza, HIV, herpes simplex virus, varicella-zoster virus, hepatitis C virus, human papillomavirus (HPV).
Figures and Concepts Referenced (for context only)
Figure 21.8: Influenza reproductive cycle including attachment, entry by endocytosis, replication, assembly, and exit by budding.
Figure 21.9: Bacteriophages attaching to a host cell; tail structures facilitate genome injection.
Figure 21.10: Temperate phage with both lytic and lysogenic cycles; prophage excision by environmental stressors.
Figure 21.11: Latent varicella-zoster infection and shingles; herpesviruses latency in nervous tissue.
Figure 21.12: HPV structure, naked icosahedral capsid, dsDNA genome, and its oncogenic potential leading to cervical cancer.
// End of notes